论文部分内容阅读
目的探讨高危型人乳头瘤病毒(HR-HPV)检测在宫颈筛查诊断非典型鳞状改变的临床价值。方法选择2010年1月至2013年12月进行的宫颈癌筛查存在宫颈上皮瘤样变(CIN)甚至宫颈癌者55例,使用阴道镜取材对所有入组者标本进行病理检查确诊,比较病理诊断与HR-HPV测定结果,并分析病理结果与HR-HPV定量关系。结果 HR-HPV测定结果中对于宫颈癌的诊断符合率与病理活检相比,达到100%,同时对于CINⅢ和CINⅡ诊断符合率与病理活检相比,均超过90%。HR-HPV水平在CINⅠ、CINⅡ、CINⅢ、宫颈癌逐渐升高。结论 HR-HPV定性结合定量检测能有效的提高非典型鳞状病变的诊断率,值得临床推广。
Objective To investigate the clinical value of high-risk human papillomavirus (HR-HPV) detection in the diagnosis of atypical squamous changes in cervical screening. Methods There were 55 cases of cervical cancer screening from January 2010 to December 2013 with cervical intraepithelial neoplasia (CIN) or even cervical cancer. All the patients were examined by pathology with colposcopy, Diagnosis and HR-HPV test results, and analyze the quantitative relationship between pathological results and HR-HPV. Results The diagnostic coincidence rate of cervical cancer in HR-HPV test results was 100% compared with that of pathological biopsy. The diagnostic coincidence rates of CINⅢ and CINⅡ were over 90% compared with biopsy. HR-HPV levels in CIN Ⅰ, CIN Ⅱ, CIN Ⅲ, cervical cancer gradually increased. Conclusion The qualitative and quantitative detection of HR-HPV can effectively improve the diagnosis of atypical squamous lesions, which is worthy of clinical application.